Диклофенак 100 мг суппозитории ректальные

国家: 吉尔吉斯斯坦

语言: 俄文

来源: Правительства Кыргызской Республики (Департамент лекарственного обеспечения и медицинской техники)

有效成分:

Диклофенак

可用日期:

ОсОО "Бификор" (ОсОО "Бификор")

ATC代码:

M01AB05

INN（国际名称）:

Diclofenac

剂量:

100 мг

药物剂型:

суппозитории ректальные

每包单位数:

№10

处方类型:

по рецепту

厂商:

ОсОО "Бификор" (Кыргызстан)

治疗领域:

Нестероидное противовоспалительное средство

產品總結:

ПЖВЛС: да

授权日期:

2018-04-18

产品特点

vTBEPX{AAIO
rlepnufi
3aMecruTe,'Ib
ArrPeKToPa
fienaprauelrra
JreKapcrBeHHoro
o6ecneqenufl
rr Me4rrrluncnofi
TexHrrKrr
MunncrepcrBa
3rPaBooxPaHeH
Kr,rprsI:crtoft
P
nyilrrena;rnen
H.K.
[
,
"&uaz"a
2018
n
I,IHCTPYKIIUq
TIO
MEAI4UI4HC
KOMY
IIPI4MEHEHIIK)
JIEKAP
CTBF'
HHOI
O
CPEACTBA
AmKJIOOEHAK
cy[[o3l4Top[u
peKTanbHble
Toproeoe
Ha3BaHIre
AI4KIIOOEHAK
cynno3l4ropl4l4
peKrarlbHble
MexgyHapoAHoe
HerIareHToBaHHoe
Ha3BaHue
[ur<.notpeuar
JlenapcrneHHas
SoPua
Cynno:uroprur
peKTanbHble
Cocrae
Ha
oAI4H
cynno:uroPuft:
Arcmueu
o
e G
eule
cml
o :,{nn.roSeHaK
Harpl4q
1
00
ur;
BcnouozametbHoe
6eulecm6o:
xr4pa
KOHAr4TepcKofo
rBepAofo
AocraroqHoe
KoJIIrqecTBO
AO
noryr{eHl4t
cyrlflo3llToplry
ltaccofi
or
1520
rvr
OnucaHue
Cyuno:ilropnu
6eloro
r4rrv
6e:roro
c
KpeMoBbIM
orreHKoM
UBera,
KoHIrr{ecKI'Ie
c
3aocrpeHHEIM
KoHUoM,
INILIrJv:nz4lApnqecKIae
c 3aKpyrneHHbIM
KoHIIOM.
fiolNurt
[MeTb
oAHopoAHy]o
Maccy
la
oAlrHaKoB)'ro
Sopry.
B
pa:pe:e
AoIIycKaeTct
Bo3AyIIIur,Iit
creprxens.
QapuarcorepareBTuqecKas
rpyrrrra
llpenaparu
Ans
reqenus
ga6oreeauuft
rocrno-MbrrrrerrHofi
cracreusr.
llporunoeocrilJll4TeJlbHble
14
nporrrBopeBMarr4qecKr.re
lpenaparbr.
Hecrepou4Hble
nporI4BoBocIIilJII'ITeJIbHbIe
rlpellaparbl.
YxcycHofi
KI'I
cJIorbI
rIpoI,I3BoAHue.,{nrno
S
eHar<.
Koa
ATX
M01AB05
@
apruano,'lorrrqecKrte
cnofi
crna
(DapmaxoduHt'ryruKu
[rzruro$eHar
flBJrrercs
Hecrepor4AHbrM
nporlrBoBocIIaJIVTeJrbHbIM
cpeAcrBoM
(HliBC).
ora:trsaer
BbrpaxeHHoe
rrporlrBoBocrraJll{TeJlbHoe,
aHanbre3l'Ipyrcuee
v
yMepeHHoe
)KaporroHr4)Karoqee
4eficrnue.
Mexanr.rsNa
yeitclezx
cB{3aH
c
yrHereHlreM aKTIrBHocrIr
ur.rKJtooKcr{reHa3br
(UOf)
-
ocHoBHofo
$eprraenra
trera6o,rragMa
apaxlrAouoeofr
KI4cJIorbI,
sersroqefics
npeArrrecrBeHHr4KoM
rrpocTarJraHAI4HoB,
Koropble
llrpalor
rnaBHylo
ponb
B
rraroreHe3e
BocrraJreHr{
g
6otu
u nr4xopaAxu.
Asalue3l4pylouee
geficrnue
o6yc:roueuo
AByM{
MexaHr43MaMrr:
neputf
epu.recKr.rM
(onocpe4onaHHo,
r{epe3
rIoAaBneHIle
cuHTe3a
rrpocrafnaH4uHon)
14
rIeHTpa,{bHbrM
(:a
cu€r
lrrru6raponaur4s.
cuHTe3a
npocrafJIaHAI{HoB
B
qeurpalrnofi
kr nepuseprauecroft